益丰药房(603939) - 2018 Q1 - 季度财报

Financial Performance - Operating revenue for the period reached CNY 1,481,632,029.10, representing a 37.41% increase year-on-year[7] - Net profit attributable to shareholders increased by 45.57% to CNY 100,958,202.35 compared to the same period last year[7] - Basic earnings per share rose by 45.55% to CNY 0.278 per share[7] - The weighted average return on equity increased by 35.83 percentage points to 3.14%[7] - Net profit for Q1 2018 was CNY 105,977,892.85, representing a 50.9% increase compared to CNY 70,185,140.78 in Q1 2017[35] - Total operating revenue for Q1 2018 reached CNY 1,481,632,029.10, a 37.3% increase from CNY 1,078,254,442.24 in the same period last year[34] Cash Flow - The net cash flow from operating activities was CNY 106,328,163.69, up 35.71% year-on-year[7] - Cash flow from operating activities for Q1 2018 was CNY 1,767,499,186.82, an increase from CNY 1,217,418,468.94 in Q1 2017[41] - The net cash flow from operating activities for the first quarter of 2018 was CNY 106,328,163.69, an increase from CNY 78,352,079.85 in the same period last year, representing a growth of approximately 35.7%[42] - Total cash inflow from operating activities amounted to CNY 1,793,519,573.05, compared to CNY 1,219,098,107.50 in the previous year, indicating a year-over-year increase of about 47%[42] - The net cash flow from investment activities was CNY 228,514,704.26, a significant recovery from a negative cash flow of CNY 25,977,809.36 in the previous year[42] - Cash and cash equivalents at the end of the period reached CNY 550,002,709.01, compared to CNY 195,206,625.37 at the end of the same period last year, marking an increase of approximately 182%[43] Assets and Liabilities - Total assets increased by 6.79% to CNY 5,107,282,613.89 compared to the end of the previous year[7] - The company's goodwill increased by 36.21% to RMB 945,467,367.60, primarily due to the acceleration of acquisition projects[16] - Total current liabilities increased to ¥1,768,288,999.91 from ¥1,557,556,592.88, a rise of approximately 13.5%[28] - Total liabilities rose to ¥1,813,511,553.97 from ¥1,602,909,291.94, reflecting an increase of about 13.1%[28] - The company's equity attributable to shareholders increased to ¥3,268,161,384.54 from ¥3,167,203,182.19, a growth of approximately 3.2%[28] Shareholder Information - The total number of shareholders at the end of the reporting period was 8,207[10] - The top ten shareholders held a total of 163,992,000 shares, accounting for 45.21% of the total share capital[13] Investments and Acquisitions - The company completed three acquisition projects during the reporting period, with one project finalized and two ongoing[20] - Investment income surged by 424.48% to RMB 5,536,546.04, driven by increased utilization of idle funds for financial management[16] - The company reported non-recurring gains of CNY 4,792,325.95 during the period[9] Operational Metrics - The number of stores increased by 269 during Q1 2018, with 92 new openings, 167 acquisitions, and 5 closures, bringing the total to 2,328 stores[18] - Total operating costs for Q1 2018 were CNY 1,348,966,803.03, up 37.1% from CNY 984,400,737.73 in Q1 2017[35] - The company reported a significant increase in sales expenses, which rose to CNY 381,722,016.80 from CNY 291,574,126.87 in Q1 2017[35]